ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,953, issued on May 12, was assigned to Evaxion A/S (Horsholm, Denmark) and Statens Serum Institut (Copenhagen S., Denmark).

"Vaccines targeting neoepitopes" was invented by Jens Kringelum (Horsholm, Denmark), Anders Bundgard Sorensen (Hrosholm, Denmark), Birgitte Rono (Horsholm, Denmark), Nadia Viborg Petersen (Horsholm, Denmark), Signe Tandrum Schmidt (Copenhagen, Denmark), Lars Vibe Andreasen (Copenhagen, Denmark) and Dennis Christensen (Copenhagen, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of vaccination utilizing a cationic liposomal adjuvant admixed with at least one neoepitope and a solvent. Also provided are unit dosages a...